Chrysant S G, Weir M R, Weder A B, McCarron D A, Canossa-Terris M, Cohen J D, Mennella R F, Kirkegaard L W, Lewin A J, Weinberger M H
Oklahoma Cardiovascular and Hypertension Center, Oklahoma City, USA.
Arch Intern Med. 1997 Nov 24;157(21):2489-94.
This report is part of a larger, multicenter, placebo-controlled study designed to test the effects of low and high salt intake on the antihypertensive action of enalapril maleate or isradipine in salt-sensitive, hypertensive patients.
To present our findings with respect to the effects of race, age, sex, and weight on the blood pressure response to low and high salt intake in salt-sensitive hypertensive patients before randomization into the larger study.
After 3 week (weeks -9 to -6) of ad lib salt intake (100-200 mmol/d of sodium), 1916 patients whose sitting diastolic blood pressure was between 95 and 115 mm Hg entered a 3-week period (week -6 to -3) of low salt intake (50-80 mmol/d of sodium) and then a 3-week period (week -3 to 0) of high salt intake (200-250 mmol/d of sodium). Of the 1916 patients, 624 were identified as being sensitive to salt by demonstrating an increase in sitting diastolic blood pressure of equal to or more than 5 mm Hg from the low to high salt intake. Of these patients, 367 were white, 156 were black, 92 were Hispanic, 8 were Asian, and 1 was American Indian. Also, 315 were men and 309, women; 351 were 55 years or younger and 273 were older than 55 years; and 195 had a body mass index of 27 or less and 429 had a body mass index higher than 27.
The sitting blood pressure decreased with salt restriction and increased with salt load in all groups of patients (P < .001). There were no statistically significant differences in the blood pressure changes to salt changes by race, age, sex, and weight.
This large, multicenter study did not demonstrate any statistically significant effect of race, age, sex, and weight on blood pressure response to salt changes in salt-sensitive hypertensive patients.
本报告是一项更大规模的多中心、安慰剂对照研究的一部分,该研究旨在测试低盐和高盐摄入对盐敏感型高血压患者中马来酸依那普利或伊拉地平降压作用的影响。
在将盐敏感型高血压患者随机纳入更大规模研究之前,阐述种族、年龄、性别和体重对低盐和高盐摄入时血压反应的影响。
在自由摄入盐(钠100 - 200 mmol/d)3周(第 - 9至 - 6周)后,1916名坐位舒张压在95至115 mmHg之间的患者进入低盐摄入(钠50 - 80 mmol/d)3周(第 - 6至 - 3周)阶段,然后进入高盐摄入(钠200 - 250 mmol/d)3周(第 - 3至0周)阶段。在这1916名患者中,624名通过显示从低盐摄入到高盐摄入时坐位舒张压升高等于或超过5 mmHg被确定为盐敏感。在这些患者中,367名是白人,156名是黑人,92名是西班牙裔,8名是亚洲人,1名是美洲印第安人。此外,315名是男性,309名是女性;351名年龄在55岁及以下,273名年龄超过55岁;195名体重指数为27或更低,429名体重指数高于27。
所有患者组坐位血压均随盐限制而降低,随盐负荷而升高(P < .00)。种族、年龄、性别和体重对盐变化时血压变化的影响无统计学显著差异。
这项大型多中心研究未显示种族、年龄、性别和体重对盐敏感型高血压患者盐变化时血压反应有任何统计学显著影响。